Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-20

Clinical Trial Update: BMS 247550 to Treat Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of BMS 247550 for renal cell carcinoma has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BMS-247550

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2012-07-20